PATENT CLAIM ANALYSIS

Application Number: 15748804
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "289000"]

Abstract:
This invention relates to methods of treating agitation comprising administering a morphinan compound or a pharmaceutically acceptable salt thereof. This invention also provides the use in methods of treating agitation and related disorders with such a morphinan compound in combination with quinidine, or pharmaceutically acceptable salt of either or both thereof.

Claim (Index 20):
The method of  claim 15 , wherein the amount of the compound of Formula I, or a pharmaceutically acceptable salt thereof, is in the range of 5 mg/day to 250 mg/day and the amount of quinidine, or a pharmaceutically acceptable salt thereof, is in the range of 1 mg/day to 20 mg/day.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15148568', '14726758', '14546173', '14208968', '13119905']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8132682240677452
- 35 USC 102 Novelty (BERT): 0.5296527422631184
- Combined Prediction Score: 0.7849066758872826
- Mean Citation Score: 332.409086
- Max Citation Score: 341.80304
- Similarity Product: 209.8277746091652

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test